Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Who would actually sell now???

<< Previous

Bullboard Posts

Next >>

Comment by NeilPaert74on Oct 19, 2020 10:38am

193 Views

Post# 31738578

RE:RE:RE:RE:Who would actually sell now???

Well, I am going to wait until AFTER te 1yr CR Phase 2 data comes in, the SP may be suggesting mis-management. Yet, I think the Phase 2 study is brilliantly designed with that second treatment they all recieve, should push CR %s up where we need them. Assuming these Docs have fixed dosage/dosimetry.

<< Previous

Bullboard Posts

Next >>

This battery metals stock is on a path to the global stage